Results 161 to 170 of about 5,794,212 (304)

Evaluating the effectiveness of integrating a clinical pharmacist into a hidradenitis suppurativa clinic within the specialty of dermatology. [PDF]

Skin Health Dis
Senawong N, Kroger K, Fisher D.
europepmc   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

Molecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani, Dominic Guanzon, Andrew Lai, Katherin Scholz‐Romero, Sarah Reed, Edita Ritmejeryte, Rohan Lourie, Naven Chetty, Kaltin Ferguson, Carlos Salomon   +9 more
wiley   +1 more source

Impact of a Clinical Pharmacist on Weight Loss Outcomes in Primary Care Patients Without Diabetes. [PDF]

J Pharm Technol
Sturtevant K, Wood M, Hitt JR, Kennedy AG, Sobel HG.   +4 more
europepmc   +1 more source

A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

Molecular Oncology, EarlyView.
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both, Ingrid A. M. Derks, Raphaël Vanleyssem, Marine Leclercq, Najla El Hachem, Pierre Close, Eric Eldering, Marco Vincent Haselager   +7 more
wiley   +1 more source

Controversy and consensus on a clinical pharmacist in primary care in the Netherlands

, 2016
Background Controversy about the introduction of a non-dispensing pharmacist in primary care practice hampers implementation. Objective The aim of this study is to systematically map the debate on this new role for pharmacists amongst all stakeholders to
Leendertse, A.J., Gier, Johan J De, Hazen, Ankie C M, Sub Pharmacoepidemiology, Sloeserwij, Vivianne M., De Wit, Niek J., Pharmacoepidemiology and Clinical Pharmacology, van der Wal, Aletta W., Hazen, A.C.M., Bouvy, Marcel L., Wal, Aletta W Van Der, de Wit, Niek J, Bouvy, M.L., De Bont, Antoinette A., Utrecht, University, de Gier, Johan J, Zwart, Dorien L M, Leendertse, Anne J., Bont, Antoinette A De, Brain, General Practice & Nursing Science, JC Overig onderzoek, HAG Zorginnovatieonderzoek, Other research (not in main researchprogram), Child Health, Curr. Onderwijs Huisartsgeneeskunde, HAG Onderwijs, Cancer   +27 more
core  

The Role of the Pharmacist in the Anticoagulant Clinic

Journal of the Royal College of Physicians of London, 1985
M, Pegg, J, Bourne, A D, Mackay, W A, Lawton, R B, Cole   +4 more
openaire   +2 more sources

Impact of Clinical Pharmacist Educational Intervention on Lipid Profile and its Clinical Outcomes. [PDF]

Saudi Med J
Alqahtani SS.
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Association between a clinical pharmacist-led multimodal remote medication intervention and individualized treatment outcomes in patients with type 2 diabetes mellitus. [PDF]

Front Endocrinol (Lausanne)
Zhou Y, Liu X, Tang K, Cai Y, Yang Q, Wang B.   +5 more
europepmc   +1 more source

Regulation of the lncRNA NEAT1 by p53‐ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC

Molecular Oncology, EarlyView.
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico, Veronica La Banca, Silvia D'Amico, Stefano Scalera, Sara Nicolai, Angelo Peschiaroli   +5 more
wiley   +1 more source